Literature DB >> 28833449

microRNA-145 downregulates SIP1-expression but differentially regulates proliferation, migration, invasion and Wnt signaling in SW480 and SW620 cells.

Anusha Sathyanarayanan1, Karthik Subramanian Chandrasekaran1, Devarajan Karunagaran1.   

Abstract

microRNA-145 (miR-145) has been shown to act as a tumor suppressor in colorectal cancer but its role in the regulation of epithelial-mesenchymal transition (EMT) is unclear. Ectopic expression of miR-145 suppressed the proliferation, migration and invasion in SW480 but surprisingly enhanced these traits in its metastatic counterpart, SW620 cells, while, antimiR-145 reversed the effects of miR-145 in both of these human colorectal cancer cells. In SW480 and SW620 cells, SMAD-interacting protein 1 (SIP1), was identified as a target of miR-145, and its expression was suppressed both at mRNA and protein levels, and siRNA-SIP1 mimicked the effects of miR-145. Further, re-introduction of SIP1 alone or its co-expression with miR-145, rescued SW480 and SW620 cells from the effects of miR-145, indicating that the distinct functions of miR-145 might be mediated, in part, through SIP1. Since Wnt signaling plays an essential role in EMT in CRC progression, the effects of miR-145 on the expression of Wnt signaling intermediates and EMT markers were studied. Re-expression of miR-145 was found to downregulate the expression of CTNNB1, TCF4, CCND1, VIM, and SNAI, but, upregulated CDH1 expression in SW480 cells. On the other hand, miR-145 exhibited an oncogenic potential in SW620 cells by actuating Wnt signaling and the expression of EMT-relevant markers. These results strongly hint that the paradoxical functions of miR-145 in the regulation of proliferation, migration and invasion might be mediated through downregulation of SIP1, and differential tuning of Wnt signaling and EMT-mediators.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMT markers; Wnt signaling; invasion; miR-145; migration; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28833449     DOI: 10.1002/jcb.26365

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

2.  [MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6].

Authors:  Yingchao Men; Lei Zhang; Hao Ai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

Review 3.  miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation.

Authors:  Paulína Pidíkova; Richard Reis; Iveta Herichova
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

Review 4.  MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).

Authors:  Yuhe Lei; Lei Chen; Ge Zhang; Aiyun Shan; Chunfeng Ye; Bin Liang; Jiayu Sun; Xin Liao; Changfeng Zhu; Yueyue Chen; Jing Wang; Enxin Zhang; Lijuan Deng
Journal:  Oncol Rep       Date:  2020-07-23       Impact factor: 3.906

Review 5.  Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).

Authors:  Igor Bryukhovetskiy; Arina Ponomarenko; Irina Lyakhova; Sergey Zaitsev; Yulia Zayats; Maria Korneyko; Marina Eliseikina; Polina Mischenko; Valerie Shevchenko; Hari Shanker Sharma; Aruna Sharma; Yuri Khotimchenko
Journal:  Int J Mol Med       Date:  2018-05-10       Impact factor: 4.101

6.  The long noncoding RNA FTH1P3 promotes the proliferation and metastasis of cervical cancer through microRNA‑145.

Authors:  Rui Lv; Qian Wen Zhang
Journal:  Oncol Rep       Date:  2019-11-20       Impact factor: 3.906

Review 7.  MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers.

Authors:  Prakash Chand Sharma; Alisha Gupta
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.